The 2015 edition of Chinese Pharmacopoeia to enhance the overall level of Chinas drug quality

The 2015 edition of Chinese Pharmacopoeia was recently adopted at the plenary session of the Executive Committee of the Tenth Chinese Pharmacopoeia Commission. On June 5, 2015, China Food and Drug Administration (CFDA) promulgated the 2015 edition of Chinese Pharmacopoeia, which will go into effect on December 1, 2015. The promulgation of the new edition of Chinese Pharmacopoeia marks the promotion of the level of China's drug use, production and supervision. It will drive the overall improvement of drug quality and play a significant role in ensuring drug safety and effectiveness for the public.